Harmony Biosciences Holdings, Inc. (HRMY) 当前追踪市盈率 (P/E) 为 10.2, 前瞻市盈率为 8.3. 追踪盈利收益率为 9.76%, 前瞻盈利收益率 12.12%. PEG 1.28. 格雷厄姆数为 $30.58.
本页证实的标准:
SharesGrow 综合评分： 82/100 其中 5/7 项标准通过。
| Year | P/E (TTM) | PEG 比率 | P/B 比率 | P/S 比率 | 股息收益率 |
|---|---|---|---|---|---|
| 2018 | -45.7 | 0.00 | 22.35 | 0.00 | - |
| 2019 | -15.5 | -0.14 | -203.43 | 393.12 | - |
| 2020 | -55.7 | 0.90 | 21.16 | 12.87 | - |
| 2021 | 70.9 | -0.46 | 13.15 | 8.03 | - |
| 2022 | 18.0 | 0.04 | 8.09 | 7.45 | - |
| 2023 | 14.9 | -0.51 | 4.11 | 3.30 | - |
| 2024 | 13.5 | 0.75 | 2.97 | 2.74 | - |
| 2025 | 13.6 | 1.74 | 2.47 | 2.48 | - |
| Year | EPS（稀释） | 营收 | 净利润 | 净利润率 |
|---|---|---|---|---|
| 2018 | $-0.81 | $0.00 | $-39.9M | - |
| 2019 | $-2.48 | $6M | $-158.05M | -2636.4% |
| 2020 | $-0.91 | $159.74M | $-51.86M | -32.5% |
| 2021 | $0.58 | $305.44M | $34.6M | 11.3% |
| 2022 | $2.97 | $437.86M | $181.47M | 41.4% |
| 2023 | $2.13 | $582.02M | $128.85M | 22.1% |
| 2024 | $2.51 | $714.73M | $145.49M | 20.4% |
| 2025 | $2.71 | $868.45M | $158.69M | 18.3% |
| Year | EPS（平均） | EPS 范围 | 营收（平均） | 营收范围 | 分析师人数 |
|---|---|---|---|---|---|
| 2026 | $3.55 | $2.69 – $4.34 | $1.02B | $983.93M – $1.05B | 7 |
| 2027 | $4.22 | $3.47 – $5.26 | $1.15B | $952.34M – $1.28B | 6 |
| 2028 | $4.87 | $1.45 – $6.48 | $1.22B | $1.22B – $1.22B | 9 |
| 2029 | $5.17 | $4.43 – $5.65 | $1.26B | $1.12B – $1.35B | 3 |
| 2030 | $4.53 | $3.88 – $4.95 | $1.06B | $943.97M – $1.14B | 3 |
